Data / Form D filings / ACUSPHERE INC
ACUSPHERE INC: Form D filings
ACUSPHERE INC, a pharmaceuticals company in Lexington, MA, filed 3 Form D notices with the SEC between 2010 and 2012. The latest, on February 22, 2012, reports $2.5 million sold of a $2.5 million offering to 1 investor.
Find out what ACUSPHERE INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 99 HAYDEN AVENUE, SUITE 385, Lexington, MA, 02421
- Phone
- (617) 648-8800
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1115143
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 22, 2012 | New notice | $2,500,000 | $2,500,000 | $0 | 1 | Feb 15, 2012 | sec.gov |
| Jul 7, 2011 | Amendment | $10,000,000 | $7,500,000 | $2,500,000 | 1 | Jun 30, 2010 | sec.gov |
| Jul 16, 2010 | New notice | $10,000,000 | $5,000,000 | $5,000,000 | 1 | Jun 30, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sandra L. Fenwick | Director | |
| Sherri C. Oberg | Executive Officer, Director | |
| Derek L. Lemke-von Ammon | Director | |
| Victor A. Hebert | Director | |
| Garen C. Bohlin | Director | |
| Bryant L. Fong | Director | |
| Martyn L. Greenacre | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Feb 20, 2012 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ACUSPHERE INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.